Northwest Biotherapeutics reported $32.94M in Debt for its fiscal quarter ending in September of 2023.





Debt Change Date
Agenus USD 35.54M 2.34M Mar/2025
AstraZeneca USD 32.24B 1.68B Jun/2026
Bristol-Myers Squibb USD 42.88B 2.18B Sep/2026
Celldex Therapeutics USD 4.9M 3M Jun/2026
Eisai JPY 254.94B 68.86B Sep/2026
Merck USD 53.91B 4.79B Jun/2026
Northwest Biotherapeutics USD 32.94M 6.93M Sep/2023
Pfizer USD 62.67B 523M Sep/2026
Plus Therapeutics USD 3.98M 372K Dec/2023
Roche Holding CHF 33.03B 1.41B Jun/2025